Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Canadian approval for Depo-Provera

April 10, 1997

Amgen obtains additional EPO patent protection

April 10, 1997

Roussel Uclaf transfers all rights and responsibilities related to mifepristone to Dr. Sakiz

April 10, 1997

GelTex issued U.S. patent for cholesterol-reducing polymers

April 10, 1997

Ergoset enters clinical trials as adjunct therapy for type II diabetes

April 10, 1997

Lilly describes agents for postmenopausal syndrome

April 9, 1997

Chronic MK-677 increases GH and IGF-I in dogs

April 8, 1997

Cobalt porphyrins for obesity from Warner-Lambert

April 8, 1997

NO-1886 increases HDL cholesterol by increasing LPL activity

April 7, 1997

Nonoxynol-9 not effective for reducing HIV transmission

April 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...